尿路致病性大肠埃希菌ST131-H30亚克隆是急诊诊所多数抗生素处方错误的原因
研究分析急诊疑似尿路感染患者尿液标本中H30亚克隆对经验性抗生素处方不匹配的影响。750份尿检阳性标本中306份(41%)培养出大肠埃希菌,H30总体患病率14%,在老年、糖尿病或留置导尿患者中更高。H30对不匹配处方的贡献总体为55%,在老年患者中为70%,在糖尿病或留置导尿患者中为100%。
要点
- H30在老年(≥70岁)、糖尿病或留置导尿患者中患病率分别为26%、43%、60%。
- H30对经验性抗生素处方不匹配的贡献总体为55%,老年患者为70%,糖尿病或导尿患者为100%。
- 具备≥2个危险因素的患者中24%尿检阳性标本为H30,对所选经验性治疗的耐药可能性为92%。
核心结论
- 多重耐药大肠埃希菌ST131-H30亚克隆是急诊诊所≥70岁或有糖尿病或留置导尿的疑似尿路感染患者中绝大多数经验性抗生素处方不匹配的原因。
研究设计与样本
- 研究分析了急诊诊所疑似尿路感染患者的尿检阳性尿液标本,评估H30对经验性处方抗生素耐药的影响。
主要发现
- 750份尿检阳性标本中306份(41%)培养出大肠埃希菌,来自35个不同的克隆群。
- H30总体患病率为14%,在年龄≥70岁患者中为26%,糖尿病患者中为43%,留置导尿患者中为60%。
- 对经验性选择抗生素方案耐药的患者总体为16%(40/246),老年患者为28%(20/71),糖尿病患者为30%(8/27),导尿患者为60%(3/5),H30阳性患者为71%(22/30)。
- H30对不匹配抗生素选择的贡献总体为55%,老年患者中为70%,糖尿病或留置导尿患者中为100%。
- 在具有≥2个因素(老年、糖尿病或留置导尿)的患者中,24%的尿检阳性标本为H30,对所选经验性治疗的耐药可能性为92%。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The pandemic spread of antibiotic resistance increases the likelihood of ineffective empirical therapy. The recently emerged fluoroquinolone-resistant Escherichia coli sequence type (ST) 131-H30R subclone (H30) is a leading cause of multidrug-resistant urinary tract infection (UTI) and bloodstream infection worldwide. METHODS: We studied the relative impact of H30 on the likelihood that bacteria isolated from urine of urgent care patients would be resistant to the empirically prescribed antibiotic regimen for UTI. RESULTS: Of 750 urinalysis-positive urine samples from urgent care patients with suspected UTI, 306 (41%) yielded E. coli, from 35 different clonal groups (clonotypes). H30 predominated (14% prevalence overall), especially among older patients (age ≥70 years: 26%) and those with diabetes (43%) or urinary catheterization (60%). Resistance to the empirically selected antibiotic regimen occurred in 16% (40/246) of patients overall, 28% (20/71) of older patients, 30% (8/27) of patients with diabetes, 60% (3/5) of catheterized patients, and 71% (22/30) of those with H30. H30's contribution to such mismatched antibiotic selection was 55% overall, 70% among older patients, and 100% among patients with diabetes or a urinary catheter. Among patients with ≥2 of these factors (older age, diabetes, or urinary catheter), 24% of all urinalysis-positive urine samples yielded H30, with a 92% likelihood of resistance to the selected empirical therapy. CONCLUSIONS: The multidrug-resistant H30 subclone of E. coli ST131 is responsible for the great majority of mismatched empirical antibiotic prescriptions for suspected UTI at an urgent care clinic among patients ≥70 years old or with diabetes or urinary catheterization.
引用
- Tchesnokova V, Riddell K, Scholes D, et al. The Uropathogenic Escherichia coli Subclone Sequence Type 131-H30 Is Responsible for Most Antibiotic Prescription Errors at an Urgent Care Clinic. Clin Infect Dis. 2019. PMID: 29961840. doi:10.1093/cid/ciy523
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。